LaBrosse Nicole insider trades
LaBrosse Nicole has filed 21 Form 4s with the SEC that we hold, all for Halozyme Therapeutics, INC. (HALO), as SVP, CHIEF FINANCIAL OFFICER. Across all of them we count 0 purchases worth $0 and 12 sales worth $3.9M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 13,240 shares of Halozyme Therapeutics, INC. worth $1.0M, dated 2025-09-10. The first filing on our record is dated 2022-02-14 and the latest 2026-02-24.
Halozyme Therapeutics, INC. (HALO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-11-15 | S, sale reported on Form 4 | 365 | $19.6K | 2022-11-16 |
| 2022-11-15 | S, sale reported on Form 4 | 4,635 | $249.5K | 2022-11-16 |
| 2023-02-16 | S, sale reported on Form 4 | 2,525 | $124.4K | 2023-02-21 |
| 2024-06-26 | S, sale reported on Form 4 | 10,000 | $518.2K | 2024-06-28 |
| 2024-06-27 | S, sale reported on Form 4 | 10,000 | $519.3K | 2024-06-28 |
| 2024-06-28 | S, sale reported on Form 4 | 10,000 | $520.4K | 2024-06-28 |
| 2024-07-22 | S, sale reported on Form 4 | 4,008 | $215.8K | 2024-07-23 |
| 2024-07-22 | S, sale reported on Form 4 | 992 | $53.8K | 2024-07-23 |
| 2025-09-10 | S, sale reported on Form 4 | 6,760 | $509.0K | 2025-09-11 |
| 2025-09-10 | S, sale reported on Form 4 | 13,240 | $1.0M | 2025-09-11 |
| 2025-09-22 | S, sale reported on Form 4 | 1,913 | $148.9K | 2025-09-23 |
| 2025-09-22 | S, sale reported on Form 4 | 314 | $24.7K | 2025-09-23 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1910662) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms